E-learning and LSI National Credentialing Register
The latest developments from within the NHS – specifically selected for industry.
Covid-19 has seen the rapid acceleration of innovative approaches to care delivery within the NHS – and healthcare leaders want to ensure that the changes are here to stay.
The NHS Confederation has launched a campaign that calls for a rest in NHS healthcare delivery in order to secure some of the positive changes that have been achieved during Covid-19.
NHS England and NHS Improvement have confirmed their approval of four new integrated care systems (ICS), which together will serve more than 6m people.
Doctors are facing shortages of vital drugs, gases and therapeutics, a survey by the British Medical Association has found.
NHS England has explained to primary care providers the detail behind its highly contentious plans to bring forward elements of the Enhanced Health in Care Homes (EHCHs) model of care from October to May 2020.
Business Secretary Alok Sharma has announced a further £84m to help support researchers develop a Covid-19 vaccine.
The National Institute for Health and Care Excellence has announced plans to work alongside a number of international organisations to share knowledge, identify treatments and develop guidance to support the global effort against Covid-19.
Over 40 countries have pledged a total of £6.5bn to go towards a global effort to development a Covid-19 vaccine and research into its diagnosis and treatment.
The Department of Health and Social Care (DHSC) has announced a £600m care home support package that aims to help reduce the spread of Covid-19 in residential settings.
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a dedicated Yellow Card reporting site, so that concerns over healthcare products that are being used to treat Covid-19 can be easily reported.
From rapid product development to healthcare delivery, Covid-19 has unleashed innovation across the service at breath-taking speed.
Sir Simon Stevens and Amanda Pritchard have written to organisations across the NHS to set out the operating environment and approach that will be taken as we enter into the second phase of the NHS’s response to Covid-19.
The business secretary, Alok Sharma, has announced the creation of a new taskforce that has been set up to rapidly develop and manufacture a coronavirus vaccine.
Covid-19 treatments could be fast-tracked through a new national clinical trial initiative that aims to accelerate the development of new drugs for patients hospitalised with the illness, in order to reduce the time taken to set up clinical studies for new therapies from months to weeks.
Global leaders have pledged to accelerate cooperation on a coronavirus vaccine and to share research, treatment and medicines across the globe during a virtual World Health Organisation meeting.
An antibody blood test for Covid-19, which claims to be 99% accurate, has been certified for use by the European Union...
The Government has announced that it will wipe the £13.4bn debt that is owed by NHS trusts, whilst also pledging to increase the Covid-19 response fund for the NHS and public services to £14bn in a bid to support the pandemic effort.
The Government has announced that it will wipe the £13.4bn debt that is owed by NHS trusts, whilst also pledging to increase the Covid-19 response fund for the NHS and public services to £14bn.
The UK government is channelling efforts to find treatments for Covid-19 on repurposing existing medication, the UK Health Secretary has said.
The Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) have announced that an additional 52 medicines can no longer be parallel exported from the UK.
Covid-19 is changing the face of healthcare delivery, acting as a catalyst for innovation and forcing into fruition many of the aims and ambitions that were set out in the NHS Long-term plan (LTP).
The National Institute for Health and Care Excellence has published several rapid response guidelines to the Covid-19 pandemic which aim to support practitioners provide the best possible care to patients.
The exceptional circumstances of Covid-19 continue to dominate the headlines and has filtered into every aspect of healthcare delivery and the life sciences industry
The government's Mandate to NHS England and NHS Improvement has been published for 2020 to 2021, setting out the objectives and budgets for the year ahead.
The impact of Covid-19 has been widespread, with the Medicines and Healthcare products Regulatory Agency (MHRA) announcing several changes to standard practice in order to help support the pandemic effort.
More than 80 medicines used to treat patients in intensive care units have been banned from parallel export from the UK, the government has announced.
What money is available for Covid-19?
The pace of change and pressure facing the NHS is representative of nothing that has been seen before. Covid-19 has bulldozed into the front and centre of everyone’s lives – and the ramifications will be widespread.
NHS England has implemented a series of measures that aim to help the NHS cope under the ‘intense pressure’ of the ‘rapidly increasing’ Covid-19 pandemic.
Simply get in touch and we will endeavour to answer your questions.
Sign in below if you have an existing account
Register for account
Please register for an account if you have never held a MIA card before
Please enter your email address